Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Upgrades 2025 full-year CDMO sales and margin outlook
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
Capricor’s BLA for Deramiocel received Priority Review in March 2025
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
Subscribe To Our Newsletter & Stay Updated
